LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency.
Saved in:
| Title: | LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. |
|---|---|
| Authors: | Tsanov KM; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Pearson DS; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Wu Z; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Han A; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Triboulet R; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA., Seligson MT; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Powers JT; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Osborne JK; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA., Kane S; Cell Signaling Technology, Inc., Danvers, Massachusetts 01923, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., Gregory RI; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA., Daley GQ; Stem Cell Transplantation Program, Division of Hematology/Oncology, Manton Center for Orphan Disease Research, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA. |
| Source: | Nature cell biology [Nat Cell Biol] 2017 Jan; Vol. 19 (1), pp. 60-67. Date of Electronic Publication: 2016 Dec 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
